Some error occured while loading the Quick View. Please close the Quick View and try reloading the page.
Although advances in neuroscience have dramatically reshaped knowledge about psychiatric medications in children and adolescents, the textbooks available to clinicians have—until now—failed to keep pace, forcing readers to choose between resources devoted to neurobiological mechanisms or those focused on clinical application. Textbook of Pediatric Psychopharmacology: Neurodevelopmental and Biopsychosocial Bases and Clinical Practice closes that divide, offering researchers, clinicians, and trainees a single resource that bridges molecular science and the human realities of clinical care.
Across 70 chapters, this textbook covers the molecular pharmacology of every major psychotropic class and the psychosocial and cultural factors that shape the outcomes that matter most to young patients and their families. Condition-specific sections provide evidence-based guidance on assessment and treatment across the full range of pediatric psychiatric presentations, from ADHD and autism to mood, anxiety, eating, and substance-related disorders.
The authors also look beyond conventional pharmacology to emerging treatments—including psychedelics and endocannabinoid modulators—that are gaining momentum in psychiatric research and practice. Dedicated sections address populations that standard texts often overlook, such as medically ill children, adolescents with intellectual disability, pregnant and postpartum teens, and youth with gender-incongruent experiences.
Drawing on the expertise of dozens of contributors from research, clinical practice, and lived experience across institutions and disciplines, Textbook of Pediatric Psychopharmacology reflects not only the current state of scientific knowledge but also the nuances, uncertainties, and ongoing debates that characterize the field. Yet the focus throughout returns to the same place: the children and adolescents being cared for and the profession's responsibility to get it right.
Lawrence K. Fung, M.D., Ph.D., is Associate Professor of Psychiatry and Behavioral Sciences at Stanford University School of Medicine, Palo Alto, California.
Laura Weiss Roberts, M.D., M.A., is Professor and Chairman, Department of Psychiatry and Behavioral Sciences, at Stanford University School of Medicine, Stanford, California.
Chapter 1. Improving Quality of Life through
Psychopharmacology and Psychosocial Considerations
Chapter 2. The
Biopsychosocial Model Fung
Chapter 3. Ethics of Pediatric
Psychopharmacology
Chapter 4. Neurodivergence and
Psychopharmacology
Chapter 5. Trajectories of Human Brain
Development
Chapter 6. Developmental Principles of
Pharmacokinetics
Chapter 7. Pharmacogenetics
Chapter 8. Genetics of
Neurodevelopmental Conditions—Attention-Deficit/Hyperactivity Disorder,
Autism Spectrum Disorder, Intellectual Disability, and Tourette
Syndrome
Chapter 9. Genetics and Developmental Neurobiology of
Schizophrenia Spectrum and Other Psychotic Disorders
Chapter 10.
Genetics and Developmental Neurobiology of Mood Disorders: A Clinical
Perspective
Chapter 11. Developmental Neurobiology of Anxiety and
Obsessive-Compulsive Disorders
Chapter 12. Genetics of Feeding and
Eating Disorders
Chapter 13. Genetics and Developmental Neurobiology of
Elimination Disorders
Chapter 14. Genetics and Developmental
Neurobiology of Sleep-Wake Disorders
Chapter 15. Genetics and
Developmental Neurobiology of Disruptive and Impulse-Control
Disorders
Chapter 16. Genetics and Developmental Neurobiology of
Substance Use Disorders
Chapter 17. Molecular and Clinical Pharmacology
of Psychostimulants
Chapter 18. Molecular and Clinical Pharmacology of
2-Adrenergic Agonists
Chapter 19. Clinical Pharmacology of
Serotonin-Norepinephrine Reuptake Inhibitors
Chapter 20. Clinical
Pharmacology of Selective Serotonin Reuptake Inhibitors
Chapter 21.
Molecular and Clinical Pharmacology of Selective Norepinephrine Reuptake
Inhibitors
Chapter 22. Molecular and Clinical Pharmacology of
Histaminergic Agents
Chapter 23. Clinical Pharmacology of Tricyclic
Antidepressants in Children and Adolescents
Chapter 24. Molecular and
Clinical Pharmacology of Atypical Antipsychotics
Chapter 25. Molecular
and Clinical Pharmacology of GABAergic Drugs
Chapter 26. Clinical and
Molecular Pharmacology of Mood Stabilizers
Chapter 27. Molecular and
Clinical Pharmacology of Glutaminergic Agents
Chapter 28. Molecular and
Clinical Pharmacology of Endocannabinoids
Chapter 29. Molecular and
Clinical Pharmacology of Psychedelics
Chapter 30. Common Factors and
Non-pharmaceutical Aspects of Pediatric Pharmacotherapy
Chapter 31.
Placebo Effects in Optimizing Pedriatic Psychopharmacology
Chapter 32.
Combining Pharmacotherapy and Psychotherapy in Children and
Adolescents
Chapter 33. Family Engagement in Pediatric
Psyychopharmacology
Chapter 34. Cultural Diversity Considerations in the
Practice of Pediatric Psychopharmacology
Chapter 35. The Art and Science
of Psychoeducation
Chapter 36. Psychiatric Evaluation in Pediatric
Psychopharmacology
Chapter 37. Running a Pediatric Psychopharmacology
Clinic – Guidance and Perspectives
Chapter 38. Assessments of
Attention-Decit Hyperactivity Disorder in Children and
Adolescents
Chapter 39. Assessments of Autism in Children and
Adolescents
Chapter 40. Assessments of Tourette Syndrome and Other Tic
Disorders in Children and Adolescents
Chapter 41. Assessments of
Childhood and Early-Onset Schizophrenia Spectrum Disorders
Chapter 42.
Assessments of Mood Disorders in Children and Adolescents
Chapter 43.
Assessment of Anxiety, Obsessive-Compulsive Disorders, and Trauma-Related
Disorders in Youth
Chapter 44. Assessments of Feeding and Eating
Disorders in Children and Adolescents
Chapter 45. Assessments of
Elimination Disorders in Children and Adolescents
Chapter 46. Assessment
of Sleep-Wake Disorders
Chapter 47. Assessment of Disruptive,
Impulse-Control, and Conflict Disorders in Children and
Adolescents
Chapter 48. Assessments of Substance-Related and Addictive
Disorders
Chapter 49. Principles of Starting, Titrating, and Stopping
Psychotropic Agents in Children and Adolescents with Psychiatric
Conditions
Chapter 50. Off-Label Use of Psychotropic Agents in Children
and Adolescents
Chapter 51. Working with the Children, Adolescents,
Parents, and Families in Various Stages of Medication Management
Chapter
52. Collaborating with Other Mental Health Providers in the Mental Health
Care of Children and Adolescents with Psychiatric Conditions
Chapter 53.
Electroconvulsive Therapy in Child and Adolescent Psychiatry
Chapter 54.
Transcranial Magnetic Stimulation in Child and Adolescent
Psychiatry
Chapter 55. Deep Brain and Vagus Nerve Stimulation in Child
and Adolescent Psychiatry
Chapter 56. Pharmacologic Treatments of
Attention-Decit Hyperactivity Disorder in Children and
Adolescents
Chapter 57. Pharmacologic Treatments in Children and
Adolescents on the Autism Spectrum
Chapter 58. Pharmacologic Treatments
of Tourette Syndrome and Other Tic Disorders in Children and
Adolescents
Chapter 59. Pharmacologic Treatments of Childhood and
Early-Onset Schizophrenia
Chapter 60. Pharmacologic Treatments of Mood
Disorders in Children and Adolescents
Chapter 61. Pharmacologic
Treatments of Anxiety Disorders, Trauma- or Stressor-Related Disorders, and
Obsessive-Compulsive and Related Disorders in Children and
Adolescents
Chapter 62. Pharmacologic Treatments of Feeding and Eating
Disorders in Children and Adolescents
Chapter 63. Pharmacologic
Treatments of Elimination Disorders in Children and Adolescents
Chapter
64. Pharmacologic Management of Sleep-Wake Disorders in Children and
Adolescents
Chapter 65. Pharmacologic Treatments of Substance-Related
and Addictive Disorders
Chapter 66. Assessments of Psychiatric
Conditions in Individuals with Intellectual Disability
Chapter 67.
Pharmacologic Treatments of Psychiatric Conditions in Individuals with
Intellectual Disability
Chapter 68. Assessments of Psychiatric
Conditions in Children and Adolescents with Gender-Incongruent
Experiences
Chapter 69. Considerations for Psychiatric Evaluation and
Treatment in Pregnant and Postpartum Adolescents
Chapter 70. Assessment
and Treatment of Psychiatric Conditions in Medically Ill Children and
Adolescents